Stockscreener 앱 받기
2.16
2.26%
-0.05
Beyond Air Inc 주식(XAIR)의 최신 뉴스
Beyond Air director Lin Yi-Chien buys $5,761 in company stock By Investing.com - Investing.com South Africa
Form 4 Beyond Air Inc: Yi-Chien Lin (10% Owner) For: 13 October - Investing.com Canada
At $2.21 a share, Beyond Air (XAIR) ten percent owner Lin Yi-Chien buys 2,607 shares. - Stock Titan
Top insider buys and sells disclosed on Friday - Investing.com
Form 4 Beyond Air Inc For: 2 October By Investing.com - Investing.com Nigeria
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com
Form 4 Beyond Air Inc For: 2 October By Investing.com - Investing.com Australia
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com UK
A 10% owner buys 20,393 shares of Beyond Air (XAIR) in three direct purchases. - Stock Titan
Ten percent owner Lin Yi-Chien holds 125,000 shares directly in Beyond Air (XAIR). - Stock Titan
Form 3 Beyond Air, Inc. For: Sep 28 Filed by: Lin Yi-Chien - StreetInsider
One holder reports sole voting power over 145,393 Beyond Air (XAIR) shares. - Stock Titan
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com Canada
Why Beyond Meat (BYND) Shares Are Getting Obliterated Today - Yahoo Finance
XAIR: Generation 2 device approval is set to unlock a $400M+ market with immediate deployment planned - TradingView
Beyond Air at cantors conference: generation 2 is the focus By Investing.com - Investing.com Canada
XAIR: Generation 2 enables immediate entry into the $400M U.S. transport market upon FDA approval - TradingView
Beyond Air at cantors conference: generation 2 is the focus - Investing.com India
Beyond Air at cantors conference: generation 2 is the focus By Investing.com - Investing.com UK
At the Waldorf Astoria, Beyond Air joins a healthcare conference Sept. 10 - Stock Titan
XAIR Initiates Coverage On Beyond Air -- Rating Set to Buy - GuruFocus
ENvue Medical Announces Reverse Stock Split to Reduce Shares to 923,718 (NASDAQ: FEED) - Kalkine Media
Lake Street Initiates Beyond Air at Buy With $10 Price Target - marketscreener.com
XAIR Looks 98.9% Undervalued on GF Value™ Despite Financial Stru - GuruFocus
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - The Manila Times
Beyond Air Announces FDA Breakthrough Device Designation for LungFit GO in NTM-PD Treatment - Quiver Quantitative
A portable treatment for hard-to-treat lung infections gets FDA breakthrough status - Stock Titan
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - Yahoo Finance
Beyond Air to Sell NeuroNOS Stake to UNIVO in Equity, Milestone Deal - citybiz
Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com - Investing.com Nigeria
Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com - Investing.com India
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - marketscreener.com
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - Yahoo Finance
Balyasny Asset Management L.P. Buys Beyond Air Inc (XAIR) -- Sha - GuruFocus
Beyond Air | 8-K: Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update - Moomoo
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com Nigeria
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com India
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com Canada
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com UK
Beyond Air (NASDAQ: XAIR) resale may lift share count to 6.2M - Stock Titan
Beyond Air Q2 net loss hits USD 7.9M - Medical Buyer
Cash per share of Beyond Air, Inc. – FWB:48L - TradingView
XAIR Q2 2026 Earnings: Narrower Loss Fails to Stem 8.74% Stock DeclineEarnings Sentiment Score - vinanet.vn
Beyond Air Sticks to Revenue Targets as LungFit PH Gen II FDA Decision Nears - finance.biggo.com
Beyond Air Inc (XAIR) Stock News Today - TradingKey
Beyond Air (XAIR) Surges 14.4% to $6.92 as Bulls Defend SupportRisk Parity Rebalance - vinanet.vn
Beyond Air (XAIR) gains 5.30% beneficial owner as Balyasny Asset Management reports 763,266 shares - Stock Titan
XAIR|Beyond Air Inc|Price:7.160|Chg%:+1.110 - TradingKey
Beyond Air (XAIR) Earnings Call zum 1. Quartal des Geschäftsjahres 2027: FDA-Katalysator, Ausblick von 8 Mio. USD für 2026 - TradingKey
Beyond Air (XAIR) Fiscal Q1 2027 Earnings Call: FDA Catalyst, $8M 2026 Outlook - TradingKey
7.22%
자본화:
|
볼륨(24시간):